MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
Authors:
Open Access
- 10 December 2019
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 122 (2) , 209-220
Abstract
Background: Mitochondrial dynamics plays an important role in tumour progression. However, how these dynamics integrate tumour metabolism in hepatocellular carcinoma (HCC) metastasis is still unclear. Methods: The mitochondrial fusion protein mitofusin-1 (MFN1) expression and its prognostic value are detected in HCC. The effects and underlying mechanisms of MFN1 on HCC metastasis and metabolic reprogramming are analysed both in vitro and in vivo. Results: Mitochondrial dynamics, represented by constant fission and fusion, are found to be associated with HCC metastasis. High metastatic HCC displays excessive mitochondrial fission. Among genes involved in mitochondrial dynamics, MFN1 is identified as a leading downregulated candidate that is closely associated with HCC metastasis and poor prognosis. While promoting mitochondrial fusion, MFN1 inhibits cell proliferation, invasion and migration capacity both in vitro and in vivo. Mechanistically, disruption of mitochondrial dynamics by depletion of MFN1 triggers the epithelial-to-mesenchymal transition (EMT) of HCC. Moreover, MFN1 modulates HCC metastasis by metabolic shift from aerobic glycolysis to oxidative phosphorylation. Treatment with glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) significantly suppresses the effects induced by depletion of MFN1. Conclusions: Our results reveal a critical involvement of mitochondrial dynamics in HCC metastasis via modulating glucose metabolic reprogramming. MFN1 may serve as a novel potential therapeutic target for HCC.Keywords
This publication has 48 references indexed in Scilit:
- Early Specialty Palliative CareNew England Journal of Medicine, 2014
- MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet PathwayHepatology, 2013
- The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target?Expert Opinion on Therapeutic Targets, 2013
- Cyclin-dependent kinases regulate splice-specific targeting of dynamin-related protein 1 to microtubulesJournal of Cell Biology, 2013
- Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progressionJournal of Clinical Investigation, 2013
- Mitochondrial dynamics regulates migration and invasion of breast cancer cellsOncogene, 2012
- Optic Atrophy 1-Dependent Mitochondrial Remodeling Controls Steroidogenesis in TrophoblastsCurrent Biology, 2012
- Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerThe FASEB Journal, 2012
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- AIDS Virus Creates Lab RiskScience, 1988